scholarly journals Improving Visualization of Female Breast Cancer Survival Estimates: Analysis Using Interactive Mapping Reports (Preprint)

2017 ◽  
Author(s):  
Awatef Ahmed Ben Ramadan ◽  
Jeannette Jackson-Thompson ◽  
Chester Lee Schmaltz

BACKGROUND The Missouri Cancer Registry collects population-based cancer incidence data on Missouri residents diagnosed with reportable malignant neoplasms. The Missouri Cancer Registry wanted to produce data that would be of interest to lawmakers as well as public health officials at the legislative district level on breast cancer, the most common non-skin cancer among females. OBJECTIVE The aim was to measure and interactively visualize survival data of female breast cancer cases in the Missouri Cancer Registry. METHODS Female breast cancer data were linked to Missouri death records and the Social Security Death Index. Unlinked female breast cancer cases were crossmatched to the National Death Index. Female breast cancer cases in subcounty senate districts were geocoded using TIGER/Line shapefiles to identify their district. A database was created and analyzed in SEER*Stat. Senatorial district maps were created using US Census Bureau’s cartographic boundary files. The results were loaded with the cartographic data into InstantAtlas software to produce interactive mapping reports. RESULTS Female breast cancer survival profiles of 5-year cause-specific survival percentages and 95% confidence intervals, displayed in tables and interactive maps, were created for all 34 senatorial districts. The maps visualized survival data by age, race, stage, and grade at diagnosis for the period from 2004 through 2010. CONCLUSIONS Linking cancer registry data to the National Death Index database improved accuracy of female breast cancer survival data in Missouri and this could positively impact cancer research and policy. The created survival mapping report could be very informative and usable by public health professionals, policy makers, at-risk women, and the public.

2017 ◽  
Author(s):  
◽  
Awatef Ahmed Ben Ramadan

Female breast cancer (FBC) is the most common invasive cancer among women of all races and ethnicities in the United States (US). About 12 percent of women in the United States will be diagnosed with breast cancer at some point in their lives. The Missouri Cancer Registry (MCR) needs to be transformed from an incidence registry to a survival registry to accurately measure the impact of Missouri public health programs. In addition, it needs to use interactive mapping reports of maps and statistics to improve data visualization. Many studies have concluded the importance of estimation of cancer incidence, mortality and survival together. We aimed to estimate breast cancer burden in Missouri during recent years in terms of breast cancer incidence, mortality and survival rates; to visualize these results; and to assess the usability of the Missouri Cancer Registry and Research Center's (MCR-ARC's) interactive maps and profile reports. FBC survival data were calculated from 2004 to 2010 after matching MCR's FBC cases with Missouri's state death records, the Social Security Death Index (SSDI) and the National Death Index (NDI). FBC incidence and mortality rates were measured from 2008 to 2012. Survival and incidence data were measured for each senate district by age, race, stage and grade at diagnosis. Mortality data was measured for each county and Senate District Groups of Counties by age and race. The rates were visualized using Instant Atlas. A scoping review and a two round usability testing study were conducted to explore perceptions of public health professionals about the use of geographic information systems and to assess the usability of the MCR-ARC's published maps. The dissertation results could be very informative for Missouri decision makers and public health leaders. Instant Atlas reports might enhance the communication between collaborators from different fields related to breast cancer and to disseminate female breast cancer data and inform health professionals and the public.


BMC Cancer ◽  
2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Jian Zhu ◽  
Jian-Guo Chen ◽  
Yong-Sheng Chen ◽  
Yong-Hui Zhang ◽  
Lu-Lu Ding ◽  
...  

2021 ◽  
Author(s):  
MAAMAR BOUKABCHA

Abstract Purpose Breast cancer is a public health problem. It impact given several, important consequences for reducing this disease. We did this study to know the situation of breast cancer and the development of cancer registry. Methods Epidemiological, statistical and computer tools are used to collect, analysis and process of the data, we used the medical records to know the data information on female breast cancer patients, by collaboration with of Bedje Sisters Public Hospitalise of Chlef (BSPHC) and the Oran Cancer Registry. Results We collected approximately 177 cases of female breast cancer, and approximately 601595 female populations during the year 2016 for Chlef region. The incidence rate is more than 29 cases of female breast cancer patients per 100000 female populations for each year. Female breast cancer patients of Chlef region is a major public health problem according to the 2016 study. Incidence rates this disease are greatly increased between 55 years and 75 years old. Conclusion Prevention, early diagnostic and different care and treatment play an important role in reducing this chronic disease in this region and why not over the worldwide?


2009 ◽  
Vol 124 (10) ◽  
pp. 2391-2399 ◽  
Author(s):  
Laura M. Woods ◽  
Bernard Rachet ◽  
Dianne O'Connell ◽  
Gill Lawrence ◽  
Elizabeth Tracey ◽  
...  

BMJ Open ◽  
2020 ◽  
Vol 10 (6) ◽  
pp. e037069
Author(s):  
Ming Li ◽  
David Roder ◽  
Katina D'Onise ◽  
David Walters ◽  
Gelareh Farshid ◽  
...  

ObjectiveUsing linked cancer registry and administrative data to monitor, tumour, node and metastases (TNM) stage and survival from female breast cancer in Australia.MethodAnalysis of 2000–2014 diagnoses with linked population-based data to investigate: (1) sociodemographic predictors of advanced stage (stages III and IV), using unadjusted and adjusted logistic regression; and (2) sociodemographic factors and stage as predictors of breast cancer survival using competing risk regression.DesignPopulation-based registry cohort.Setting and participants14 759 South Australian women diagnosed in 2000–2014.Primary and secondary outcome measuresStage and survival.ResultsAt diagnosis, 46% of women were classified as stage I, 39% as stage II, 12% as stage III and 4% as stage IV. After adjusting for sociodemographic factors, advanced stage was more common: (1) for ages <50 years; and although not statistically significant, for ages 80+ years; and (2) in women from socioeconomically disadvantaged areas. Compared with 2000–2004 diagnoses, stage and sociodemographic adjusted risks (sub-HRs (SHRs)) of breast cancer death were lower in 2005–2009 (SHR 0.75, 95% CI 0.67 to 0.83) and 2010–2015 (SHR 0.57, 95% CI 0.48 to 0.67). Compared with stage I, the SHR was 3.87 (95% CI 3.32 to 4.53) for stage II, 10.87 (95% CI 9.22 to 12.81) for stage III, and 41.97 (95% CI 34.78 to 50.65) for stage IV. Women aged 70+ years at diagnosis and those living in the most socioeconomically disadvantaged areas were at elevated risk of breast cancer death, independent of stage and sociodemographic factors.ConclusionsStage varied by age, diagnostic period and socioeconomic status, and was a stronger predictor of survival than other statistically significant sociodemographic predictors. Achieving earlier diagnosis outside the original BreastScreen target of 50–69 years (as applying <2014) and in residents of socioeconomically disadvantaged areas likely would increase cancer survival at a population level.


2020 ◽  
Vol 52 (3) ◽  
pp. 739-746
Author(s):  
Eun-Gyeong Lee ◽  
So-Youn Jung ◽  
Myong Cheol Lim ◽  
Jiwon Lim ◽  
Han-Sung Kang ◽  
...  

PurposeThis study aimed to determine the incidence of male breast cancer (MBC) and its survival outcomes in Korea, and to compare these results to those for female breast cancer (FBC).Materials and MethodsWe searched the Korea Central Cancer Registry and identified 227,122 breast cancer cases that were diagnosed between 1999 and 2016. Demographic and clinical characteristics and overall survival (OS) rates were estimated according to sex, age, histological type, and cancer stage.ResultsThe 227,122 patients included 1,094 MBC cases and 226,028 FBC cases. Based on the age-standardized rate, the male: female ratio was 0.0055:1. The most common ages at diagnosis were 60-69 years for MBC and 40-49 years for FBC (p < 0.001). Male patients were less likely than female patients to receive adjuvant radiotherapy (7.5% vs. 21.8%, p < 0.001) or adjuvant chemotherapy (40.1% vs. 55.4%, p < 0.001). The 5-year OS rates after diagnosis were 88.8% for all patients, although it was significantly lower for MBC than for FBC (76.2% vs. 88.9%, p < 0.001). In both groups, older age (≥ 60 years) was associated with shorter survival. The 5-year OS rates for the invasive histological types were 75.8% for men and 89.0% for women. The 5-year OS rates in both groups decreased with increasing cancer stage.ConclusionMBC was diagnosed at older ages than FBC, and male patients were less likely to receive radiotherapy and chemotherapy. The survival outcomes were worse for MBC than for FBC, with even poorer outcomes related to older age, the inflammatory histological types, and advanced stage. It is important that clinicians recognize the differences between FBC and MBC when treating these patients.


Sign in / Sign up

Export Citation Format

Share Document